Grantham, Mayo, Van Otterloo & Co (GMO)’s CareTrust REIT CTRE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
– Sell
-24,800
Closed -$583K – 701
2019
Q3
$583K Sell
24,800
-67,500
-73% -$1.59M ﹤0.01% 617
2019
Q2
$2.19M Buy
+92,300
New +$2.24M 0.02% 431

Other funds holding CTRE

Grantham, Mayo, Van Otterloo & Co (GMO)'s CTRE Position: Q4 2019 in Review

Grantham, Mayo, Van Otterloo & Co (GMO) sold out of CareTrust REIT (CTRE) in Q4 2019, closing a stake of 24,800 shares — an estimated $583K sold.

Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in CTRE in Q2 2019 and held it in 2 quarters. The position peaked at $2.19M in Q2 2019. 218 funds tracked by Wall St. Rank hold CTRE as of Q4 2019.

  • Grantham, Mayo, Van Otterloo & Co (GMO) reported no remaining CareTrust REIT position as of Q4 2019 after selling out during the quarter.
  • Grantham, Mayo, Van Otterloo & Co (GMO) sold 24,800 CareTrust REIT shares in Q4 2019, an estimated $583K.
  • Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in CareTrust REIT in Q2 2019 and held it in 2 quarters.
  • Grantham, Mayo, Van Otterloo & Co (GMO)'s CareTrust REIT position peaked at $2.19M in Q2 2019.
  • 218 funds tracked by Wall St. Rank held CareTrust REIT as of Q4 2019.

Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q4 2019, filed 13 Feb 2020.